{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:26:13Z","timestamp":1766075173921,"version":"3.48.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDRIG\/L3\/2023-0557"],"award-info":[{"award-number":["EMDRIG\/L3\/2023-0557"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023445","name":"Business in the Streets","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/001889"],"award-info":[{"award-number":["CRG\/2022\/001889"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/005290"],"award-info":[{"award-number":["CRG\/2022\/005290"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109206","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:27:07Z","timestamp":1762302427000},"page":"109206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of (E)-3-amino-N\u2032-substituted benzylidene-6-chloropyrazine-2-carbohydrazide derivatives as anti-mycobacterial agents"],"prefix":"10.1016","volume":"167","author":[{"given":"Boddupalli Venkata Siva","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puja","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hrushikesh S.","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchi Jain","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankaranarayanan","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kondapalli Venkata Gowri Chandra","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"World Health Organization (WHO) - Global Tuberculosis Control","key":"10.1016\/j.bioorg.2025.109206_bb0005"},{"issue":"101921","key":"10.1016\/j.bioorg.2025.109206_bb0010","first-page":"10","article-title":"HIV and tuberculosis: the paradox of dual illnesses and the challenges of their fighting in the history","volume":"122","author":"Canetti","year":"2020","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","article-title":"Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019","volume":"24","author":"Lv","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109206_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"issue":"1303","key":"10.1016\/j.bioorg.2025.109206_bb0030","article-title":"Design, synthesis and biological evaluation of novel pyrido-[2, 3-d]-pyrimidin-2-amine analogues as antimycobacterial agents","author":"Kumar","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109206_bb0035","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1517\/13543776.2012.714370","article-title":"Pyrazine derivatives: a patent review (2008\u2013present)","volume":"22","author":"Ferreira","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0040","first-page":"13","article-title":"Synthesis of some 2, 3, 6, 8-tetraarylimidazo [1, 2-a] pyrazine derivatives by using either reflux or microwave irradiation method, and investigation their anticancer activities","volume":"35","author":"Kayagil","year":"2011","journal-title":"Turk. J. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109206_bb0045","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1747-0285.2012.01332.x","article-title":"Ligustrazine Derivatives. Part 4: design, synthesis, and biological evaluation of novel Ligustrazine-based stilbene Derivatives as potential cardiovascular agents","volume":"79","author":"Deng","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"issue":"14","key":"10.1016\/j.bioorg.2025.109206_bb0050","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1016\/j.bmc.2010.06.002","article-title":"Synthesis and pharmacological evaluation of pyrazine N-acylhydrazone derivatives designed as novel analgesic and anti-inflammatory drug candidates","volume":"18","author":"da Silva","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109206_bb0055","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0022-3565(25)20240-3","article-title":"Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects","volume":"258","author":"France","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2014.61","article-title":"Aspartate decarboxylase (PanD) as a new target of pyrazinamide in mycobacterium tuberculosis","volume":"3","author":"Shi","year":"2014","journal-title":"Emerging Microbes & Infections."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41467-019-14238-3","article-title":"The molecular basis of pyrazinamide activity on mycobacterium tuberculosis PanD","volume":"11","author":"Sun","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109206_bb0070","article-title":"Structural and genomic insights into pyrazinamide resistance in mycobacterium tuberculosis underlie differences between ancient and modern lineages","volume":"23","author":"Tunstall","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109206_bb0075","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.tips.2019.10.005","article-title":"Pharmacological and molecular mechanisms behind the sterilizing activity of pyrazinamide","volume":"40","author":"Gopal","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015785","article-title":"Crystal structure of the pyrazinamidase of mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide","volume":"6","author":"Petrella","year":"2011","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109206_bb0085","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/tmi.14051","article-title":"Genome sequencing analysis of the pncA, rpsA and panD genes responsible for pyrazinamide resistance of mycobacterium tuberculosis from Indonesian isolates","volume":"29","author":"Rukmana","year":"2024","journal-title":"Trop. Med. Int. Health"},{"issue":"74","key":"10.1016\/j.bioorg.2025.109206_bb0090","article-title":"Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents","volume":"15","author":"Hegde","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109206_bb0095","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/acsinfecdis.2c00133","article-title":"Structural and mechanistic insights into mycobacterium abscessus aspartate decarboxylase PanD and a pyrazinoic acid-derived inhibitor","volume":"8","author":"Saw","year":"2022","journal-title":"ACS Infectious Diseases."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109206_bb0100","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bmcl.2013.12.054","article-title":"Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation","volume":"24","author":"Servusov\u00e1","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109206_bb0105","first-page":"170","article-title":"Synthesis, mycobacterium tuberculosis H37Rv inhibitory activity, and molecular docking study of pyrazinamide analogs","volume":"13","author":"Zulqurnain","year":"2023","journal-title":"Journal of Applied Pharmaceutical Science."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109206_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2020.102915","article-title":"Synthesis, and biological screening of chloropyrazine conjugated benzothiazepine derivatives as potential antimicrobial, antitubercular and cytotoxic agents","volume":"14","author":"Shaik","year":"2021","journal-title":"Arab. J. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109206_bb0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/11040242","article-title":"Substituted pyrazinecarboxamides: synthesis and biological evaluation","volume":"11","author":"Dolezal","year":"2006","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109206_bb0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/molecules22020223","article-title":"Synthesis of novel pyrazinamide derivatives based on 3-chloropyrazine-2-carboxamide and their antimicrobial evaluation","volume":"22","author":"Jandourek","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/hc-2020-0109","article-title":"Design, synthesis and study of antibacterial and antitubercular activity of quinoline hydrazone hybrids","volume":"26","author":"Shruthi","year":"2020","journal-title":"Heterocycl. Commun."},{"issue":"144","key":"10.1016\/j.bioorg.2025.109206_bb0130","article-title":"Designing new antitubercular isoniazid derivatives with improved reactivity and membrane trafficking abilities","volume":"1","author":"de Faria","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"96","key":"10.1016\/j.bioorg.2025.109206_bb0135","article-title":"Novel pyrazine based anti-tubercular agents: design, synthesis, biological evaluation and in silico studies","volume":"1","author":"Hassan","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2025.109206_bb0140","doi-asserted-by":"crossref","first-page":"15295","DOI":"10.3390\/ijms232315295","article-title":"Synthesis, biological evaluation and computational studies of new hydrazide derivatives containing 1, 3, 4-oxadiazole as antitubercular agents","volume":"23","author":"Zampieri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109206_bb0145","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.3390\/pharmaceutics15092185","article-title":"Molecular hybridization as a strategy for developing artemisinin-derived anticancer candidates","volume":"15","author":"Marchesi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109206_bb0150","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1021\/acs.jcim.2c00443","article-title":"MolHyb: a web server for structure-based drug design by molecular hybridization","volume":"62","author":"Wang","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109206_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126846","article-title":"The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: synthesis via click approach and molecular docking of pyrazine-1, 2, 3-triazoles","volume":"30","author":"Reddyrajula","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109206_bb0160","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.bmcl.2016.03.055","article-title":"Synthesis and docking studies of pyrazine\u2013thiazolidinone hybrid scaffold targeting dormant tuberculosis","volume":"26","author":"Chitre","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109206_bb0165","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2174\/1570180816666190329222636","article-title":"Recursive partitioning analysis and anti-tubercular screening of 3-aminopyrazine-2-carbohydrazide derivatives","volume":"16","author":"Miniyar","year":"2019","journal-title":"Lett. Drug Des. Discovery"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109206_bb0170","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jhet.883","article-title":"Synthesis of N-Substituted-6-alkoxypteridin-4-amine","volume":"49","author":"Duan","year":"2012","journal-title":"J. Heterocyclic Chem."},{"issue":"263","key":"10.1016\/j.bioorg.2025.109206_bb0175","article-title":"FTIR spectroscopic evidence for new isomers of 3-aminopyrazine-2-carboxylic acid formed in argon matrices upon UV irradiations","volume":"15","author":"Pagacz-Kostrzewa","year":"2021","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109206_bb0180","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1016\/j.bmcl.2011.09.044","article-title":"Synthesis and preliminary evaluation of amiloride analogs as inhibitors of the urokinase-type plasminogen activator (uPA)","volume":"21","author":"Matthews","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109206_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115422","article-title":"Predictive models for estimating cytotoxicity on the basis of chemical structures","volume":"28","author":"Sun","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109206_bb0190","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/molecules22101685","article-title":"Antibacterial and antitubercular activities of cinnamylideneacetophenones","volume":"22","author":"Polaquini","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0195","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/s41598-022-09210-z","article-title":"Cytotoxicity, early safety screening, and antimicrobial potential of minor oxime constituents of essential oils and aromatic extracts","volume":"12","author":"Surowiak","year":"2022","journal-title":"Sci. Rep."},{"issue":"29","key":"10.1016\/j.bioorg.2025.109206_bb0200","doi-asserted-by":"crossref","first-page":"18333","DOI":"10.1039\/D2RA02163C","article-title":"Pyridine appended 2-hydrazinylthiazole derivatives: design, synthesis, in vitro and in silico antimycobacterial studies","volume":"12","author":"Matsa","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109206_bb0205","article-title":"Elucidation of the essentiality of lumazine synthase (RibH) for mycobacterium tuberculosis survival and discovery of potent inhibitors for enhanced antimycobacterial therapy","author":"Singh","year":"2023","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0210","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1038\/s41598-020-65766-8","article-title":"Survey of drug resistance associated gene mutations in mycobacterium tuberculosis, ESKAPE and other bacterial species","volume":"10","author":"Ghosh","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0215","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109206_bb0220","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109206_bb0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"year":"2024","series-title":"2024\u20134: Maestro","author":"Maestro","key":"10.1016\/j.bioorg.2025.109206_bb0230"},{"issue":"21","key":"10.1016\/j.bioorg.2025.109206_bb0235","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212 ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109206_bb0240","series-title":"Maestro-Desmond Interoperability Tools","first-page":"2024","author":"Desmond, Schr\u00f6dinger Release 2024\u20134: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY","year":"2024"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109206_bb0245","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"year":"2024","series-title":"Schr\u00f6dinger Release 2024\u20134: Prime, Schr\u00f6dinger, LLC, New York, NY","author":"Prime","key":"10.1016\/j.bioorg.2025.109206_bb0250"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:22:48Z","timestamp":1766074968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825010867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"alternative-id":["S0045206825010867"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109206","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of (E)-3-amino-N\u2032-substituted benzylidene-6-chloropyrazine-2-carbohydrazide derivatives as anti-mycobacterial agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109206"}}